Those results stand in line with the study of Modarai and colleagues, in which ATRA-treatment of human CRC lines decreased proliferation, sphere formation and ALDH + CSC population size by inducing neuroendocrine differentiation [29]. The gene discussed is LDHA; the disease is colorectal carcinoma.